To Örebro University

oru.seÖrebro universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Home phototherapy for hyperbilirubinemia in neonates: an unblinded multicentre randomised controlled trial
Örebro universitet, Institutionen för medicinska vetenskaper. Region Örebro län. Department of Paediatrics.ORCID-id: 0000-0003-3762-7627
Örebro universitet, Institutionen för hälsovetenskaper. Department of Paediatrics, Örebro University Hospital, Örebro, Sweden.ORCID-id: 0000-0002-5996-2584
Department of Paediatrics, Karlstad Hospital, Karlstad, Sweden.
Department of Paediatrics, Falun Hospital, Falun, Sweden.
Vise andre og tillknytning
2023 (engelsk)Inngår i: Örebro University's Nobel Day Festivities: Book of Abstracts, 2023Konferansepaper, Oral presentation with published abstract (Fagfellevurdert)
Abstract [en]

Background/Objective: The aim of this study was to assess whether home phototherapy is a safe alternative to hospital treatment.

Method: This was a randomised controlled, multicentre, trial in which term newborns with a total serum bilirubin of 300-400 μmol/ were randomized to either home phototherapy or conventional in-hospital phototherapy.The outcome measurements were parent-infant bonding, stress and measurements of safety and feasibility. A descriptive qualitative study based on interviews was performed as well as a health economic analysis.

Result: 147 patients were recruited from 6 hospitals, Results showed no difference between groups in the safety and feasibility outcomes. Parents in the intervention group had better scores on bonding and lower levels of stress. The interviews showed that parents felt secure at home. The cost per patient was €337 for home phototherapy compared with €1156 for the hospital alternative indicating average cost savings of €819 or 71% per patient.

Conclusion: Home phototherapy can be considered a safe and feasible alternative to hospital care for well selected patients. It improves bonding and stress for parents and reduces health care costs. Since the first publication from this study was published home phototherapy is now recommended by the American Academy of Pediatrics as an alternative to hospital care for patients with uncomplicated hyperbilirubinemia.

sted, utgiver, år, opplag, sider
2023.
Emneord [en]
Newborn infant, phototherapy
HSV kategori
Identifikatorer
URN: urn:nbn:se:oru:diva-110073ISBN: 9789187789922 (digital)OAI: oai:DiVA.org:oru-110073DiVA, id: diva2:1817573
Konferanse
Nobel Day Festivites
Tilgjengelig fra: 2023-12-06 Laget: 2023-12-06 Sist oppdatert: 2025-07-08bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Person

Pettersson, MiriamEriksson, MatsBlomberg, KarinRyen, LindaOhlin, Andreas

Søk i DiVA

Av forfatter/redaktør
Pettersson, MiriamEriksson, MatsBlomberg, KarinRyen, LindaOhlin, Andreas
Av organisasjonen

Søk utenfor DiVA

GoogleGoogle Scholar

isbn
urn-nbn

Altmetric

isbn
urn-nbn
Totalt: 408 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf